Total antioxidant capacity - a novel early bio-chemical marker of oxidative stress in HIV infected individuals
Oxidative stress induced by the production of reactive oxygen species may play a critical role in the stimulation of HIV replication and the development of immunodeficiency. This study was conducted as there are limited and inconclusive studies on the significance of a novel early marker of oxidative stress which can reflect the total antioxidant capacity in HIV patients.
Methods: Total antioxidant capacity (TAC) and lipid peroxidation were evaluated in 50 HIV-1 seropositive patients (including HIV-1 symptomatics and asymptomatics).
Controls included 50 age and sex matched and apparently healthy HIV-1 seronegative subjects. Serum malondialdehyde (MDA), Total antioxidant capacity[TAC] (by ferric reducing antioxidant power assay), vitamin E, vitamin C and superoxide dismutase (SOD) enzyme activity were estimated among controls and cases.
Statistical comparisons and correlations at 5% level of significance were determined.Results and Discussion: The mean MDA concentrations were significantly elevated in both HIV-1 asymptomatic (CD4+ count >500 cells/microliter) and HIV-1 symptomatic (CD4+ count <500 cells/microliter) groups (Mean +/- S.D values were 2.2 +/- 0.7 nmol/ml and 2.8 +/- 0.8 nmol/ml respectively) when compared with the control group (Mean +/- S.D value was 0.9 +/- 0.2 nmol/ml) (p<0.01). The mean TAC of HIV- 1 asymptomatic and HIV-1 symptomatic (Mean +/- S.D values were 754.6+/-135.6 umol/L and 676.6+/-154.1 umol/L respectively) patients were significantly reduced compared with the control group (Mean +/- S.D value was 1018.7+/-125.6 umol/L) (p<0.01).
Also, there were significantly decreased levels of vitamin E, vitamin C and SOD among HIV-1 seropositive patients(controls >asymptomatic >symptomatic) compared to controls (p<0.01). TAC showed significant negative correlation with MDA among HIV-1 infected patients (p<0.01).
Conclusion: Our results clearly show that severe oxidative stress occurs in the HIV-1 seropositive patients in comparison with controls, and increases significantly with the progression of disease, i.e.
HIV-1 symptomatics >asymptomatics >controls. TAC can be used as a novel early bio-chemical marker of oxidative stress in HIV-1 infected patients which may result in reduced tissue damage by free radicals and help to monitor and optimize antioxidant therapy in such patients.
Author: D SureshVamseedhar AnnamK PratibhaB Maruti Prasad
Credits/Source: Journal of Biomedical Science 2009, 16:61
Published on: 2009-07-07
Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please
make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.
Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo
|
|
